FNY Among Mid Cap ETFs
End-of-day Nov 11, 2026 · 93 Mid cap ETFs by YTD
Loading…
Getting the latest data.
First TrustUS Stock StylesMid Cap#493 of 695 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +1.2% | 0.0% | +0.8% | −7.2% | +9.1% | +8.3% | +71.8% | +27.4% | +404.1% |
| Peer average | +0.8% | −0.2% | +1.9% | −3.5% | +14.0% | +15.9% | +61.8% | +40.5% | — |
| S&P 500 · VOO | +1.3% | −0.9% | −2.4% | −2.1% | +12.3% | +12.8% | +81.3% | +75.3% | — |
$11 of every $1,000 in FNY is Glaukos
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GKOSGlaukos | Healthcare | 1.07% | $106.82 | 25K | $5.9M |
| 2 | HNGEHinge Health, () | Healthcare | 0.94% | $94.10 | 42K | $5.2M |
| 3 | VSXYVictoria's Secret | Consumer Cyclical | 0.93% | $92.96 | 46K | $5.1M |
| 4 | CONConcentra Group Parent | Healthcare | 0.92% | $92.05 | 119K | $5.1M |
| 5 | CHYMChime Financial, () | Technology | 0.91% | $90.70 | 153K | $5.0M |
| 6 | LFSTLifeStance Health Group | Healthcare | 0.90% | $89.87 | 340K | $4.9M |
| 7 | EXELExelixis | Healthcare | 0.90% | $89.72 | 70K | $4.9M |
| 8 | PACSPACS Group | Healthcare | 0.88% | $87.75 | 98K | $4.8M |
| 9 | CRLCharles River Laboratories International | Healthcare | 0.87% | $87.03 | 14K | $4.8M |
| 10 | HAEHaemonetics | Healthcare | 0.86% | $86.28 | 39K | $4.8M |
| 11 | XMTRXometry, () | Industrials | 0.86% | $86.14 | 40K | $4.7M |
| 12 | FIVEFIVE Below | Consumer Cyclical | 0.86% | $85.73 | 19K | $4.7M |
| 13 | TGTXTG Therapeutics | Healthcare | 0.86% | $85.54 | 73K | $4.7M |
| 14 | VCTRVictory Capital () | Financial Services | 0.85% | $84.85 | 37K | $4.7M |
| 15 | COKECoca-Cola Consolidated | Consumer Defensive | 0.84% | $84.07 | 22K | $4.6M |
of the $527B in 107 Mid cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GKOS | Glaukos | 1.07% |
| 2 | HNGE | Hinge Health, () | 0.94% |
| 3 | VSXY | Victoria's Secret & | 0.93% |
| 4 | CON | Concentra Group Parent | 0.92% |
| 5 | CHYM | Chime Financial, () | 0.91% |
| 6 | LFST | LifeStance Health Group | 0.90% |
| 7 | EXEL | Exelixis | 0.90% |
| 8 | PACS | PACS Group | 0.88% |
| 9 | CRL | Charles River Laboratories International | 0.87% |
| 10 | HAE | Haemonetics | 0.86% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 26, 2025 | Jun 30, 2025 | $0.0297 |
| Dec 13, 2024 | Dec 31, 2024 | $0.14 |
| Sep 26, 2024 | Sep 30, 2024 | $0.31 |
| Dec 22, 2023 | Dec 29, 2023 | $0.0619 |
| Jun 27, 2023 | Jun 30, 2023 | $0.0218 |
| Mar 24, 2023 | Mar 31, 2023 | $0.0830 |
| Dec 23, 2022 | Dec 30, 2022 | $0.11 |
| Sep 23, 2022 | Sep 30, 2022 | $0.0225 |
| Dec 24, 2020 | Dec 31, 2020 | $0.0697 |
| Sep 24, 2020 | Sep 30, 2020 | $0.0897 |
| Mar 26, 2020 | Mar 31, 2020 | $0.0040 |
| Dec 13, 2019 | Dec 31, 2019 | $0.11 |